The effect of hypnotherapy on emotional problems in psychosomatic patients

Studying the effectiveness of hypnotherapy on pain anxiety, negative affect, emotional distress, and emotional alexithymia in female psychosomatic patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241204063935N1

Enrollment

Registered

2025-05-19

Start date

2025-05-11

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosomatic disorder. Somatoform disorders

Interventions

Intervention 1: Intervention group: participants will undergo structured hypnotherapy, which will be delivered over seven treatment sessions. The sessions will include an introduction to hypnosis, cor

Eligibility

Sex/Gender

Female

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: People aged 25 to 50 People with a diploma or higher education

Exclusion criteria

Exclusion criteria: People who have a concurrent acute psychiatric disorder Anemia Thyroid diseases

Design outcomes

Primary

Measure	Time frame
Pain anxiety: Pain anxiety is defined as the level of worry, fear, or mental anxiety associated with the experience of pain in psychosomatic patients. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: The level of pain anxiety will be measured using the McCracken Pain Anxiety Questionnaire.;DNegative affect: Negative affect is defined as the persistent experience of unpleasant emotions such as stress, anxiety, and depression in psychosomatic patients. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: Watson et al. Positive and Negative Affect Scale.;Emotional distress: Emotional distress is defined as an unpleasant mental state resulting from the inability to regulate emotions and feelings. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: Simmons and Gahr Distress Tolerance Scale (2005).;Emotional alexithymia: Emotional alexithymia is defined as the inability to recognize, understand, and express one's own emotions. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: Toronto Emotional Aphasia Scale, Bagby et al. (1994).	—

Measure

Time frame

Pain anxiety: Pain anxiety is defined as the level of worry, fear, or mental anxiety associated with the experience of pain in psychosomatic patients. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: The level of pain anxiety will be measured using the McCracken Pain Anxiety Questionnaire.;DNegative affect: Negative affect is defined as the persistent experience of unpleasant emotions such as stress, anxiety, and depression in psychosomatic patients. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: Watson et al. Positive and Negative Affect Scale.;Emotional distress: Emotional distress is defined as an unpleasant mental state resulting from the inability to regulate emotions and feelings. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: Simmons and Gahr Distress Tolerance Scale (2005).;Emotional alexithymia: Emotional alexithymia is defined as the inability to recognize, understand, and express one's own emotions. Timepoint: This variable will be measured at three time points (pretest, posttest, and follow-up). Method of measurement: Toronto Emotional Aphasia Scale, Bagby et al. (1994).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme soghra karbalaei harofte

Islamic Azad University

karbalaei1400@yahoo.com+98 54 3342 9733

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026